Cryomass Technologies Inc. (CRYM)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Cryomass Technologies Market Cap
Cryomass Technologies has a market cap or net worth of $240.00 as of August 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
240.00
Enterprise Value
5.81M
Revenue
37.74K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 29, 2016, Cryomass Technologies's market cap has decreased from 347.60K to 240.00, a decrease of -99.93%. That is a compound annual growth rate of -55.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 240.00 | -99.99% |
| Dec 31, 2024 | 4.11M | -54.09% |
| Dec 29, 2023 | 8.96M | -76.12% |
| Dec 30, 2022 | 37.51M | -29.46% |
| Dec 31, 2021 | 53.18M | 179.14% |
| Dec 31, 2020 | 19.05M | -71.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |